Prudential Financial Reports 11.4% Stake in Cabaletta Bio, Inc. (CABA)

Prudential Financial, Inc. filed a Schedule 13G/A on June 5, 2026, disclosing a significant increase in its position in Cabaletta Bio, Inc. (CABA). As of May 31, 2026, the filer reported beneficial ownership of 24,267,980 shares of common stock, representing 11.4% of the company. This marks a substantial increase from a previously reported 0% position. The filing indicates that Prudential Financial, acting as a parent holding company, shares dispositive power over all 24,267,980 shares and shared voting power over 19,465,084 shares. Specifically, the shares are held by its subsidiary, Jennison Associates LLC, an investment adviser. The securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. Cabaletta Bio, Inc. is a Philadelphia-based biotechnology company. The filing was signed by Richard Baker, Second Vice President of Prudential Financial, Inc.